Annalisa Ciabattini

About Annalisa Ciabattini

Annalisa Ciabattini, With an exceptional h-index of 24 and a recent h-index of 18 (since 2020), a distinguished researcher at Università degli Studi di Siena, specializes in the field of Immunology, microbiology, flow cytometry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Anti-capsule human monoclonal antibodies protect against hypervirulent and pandrug-resistant Klebsiella pneumoniae

Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 omicron variant

Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study

Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a Machine Learning approach

Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability

Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?

Annalisa Ciabattini Information

University

Position

___

Citations(all)

2089

Citations(since 2020)

1237

Cited By

1214

hIndex(all)

24

hIndex(since 2020)

18

i10Index(all)

38

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Annalisa Ciabattini Skills & Research Interests

Immunology

microbiology

flow cytometry

Top articles of Annalisa Ciabattini

Anti-capsule human monoclonal antibodies protect against hypervirulent and pandrug-resistant Klebsiella pneumoniae

bioRxiv

2024/2/14

Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot

European Journal of Human Genetics

2024/1

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 omicron variant

2024/12/31

Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study

Vaccines

2024/3/29

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a Machine Learning approach

2024/2/14

Matteo Augello
Matteo Augello

H-Index: 1

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

iScience

2023/12/15

Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability

Clinical Microbiology and Infection

2023/12/1

Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?

Microorganisms

2023/10/22

Mario Tumbarello
Mario Tumbarello

H-Index: 49

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

Trajectory of spike-specific B cells elicited by two doses of BNT162b2 mRNA vaccine

Cells

2023/6/23

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV

Communications Medicine

2023/1/30

Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients

2022

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

Simone Lucchesi
Simone Lucchesi

H-Index: 3

Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines

2022

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies.

2022

Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine.

2022

Human monoclonal antibodies to the spike subdomain 1 neutralize SARS-CoV-2 and its variants of concern

Swiss Medical Weekly

2022

Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine

2022

Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2

2022/11/24

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

Frontiers in immunology

2022/9/29

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

Monitoring anti-PEG antibodies level upon repeated lipid nanoparticle-based COVID-19 vaccine administration

International Journal of Molecular Sciences

2022/8/9

Simone Lucchesi
Simone Lucchesi

H-Index: 3

Annalisa Ciabattini
Annalisa Ciabattini

H-Index: 14

See List of Professors in Annalisa Ciabattini University(Università degli Studi di Siena)